Kirik, D <br/><br/>
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.  [electronic resource] 

 -  The European journal of neuroscience  Apr 2001 
 - 1589-99 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0953-816X 
<br/><br/><label>Standard No.: </label>10.1046/j.0953-816x.2001.01534.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphetamine--pharmacology<br/>Animals<br/>Corpus Striatum--enzymology<br/>Dopamine--metabolism<br/>Female<br/>Glial Cell Line-Derived Neurotrophic Factor<br/>Infusion Pumps<br/>Injections, Intraventricular<br/>Motor Activity--drug effects<br/>Nerve Degeneration--chemically induced<br/>Nerve Growth Factors<br/>Nerve Tissue Proteins--pharmacology<br/>Oxidopamine<br/>Parkinson Disease--pathology<br/>Parkinson Disease, Secondary--chemically induced<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rotation<br/>Stereotyped Behavior--physiology<br/>Substantia Nigra--drug effects<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism